- Home
- PLYM vs DYN Comparison
PLYM vs DYN Comparison
Compare PLYM & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYM
- DYN
- Stock Information
- Founded
- PLYM 2011
- DYN 1984
- Country
- PLYM United States
- DYN United States
- Employees
- PLYM N/A
- DYN N/A
- Industry
- PLYM Real Estate Investment Trusts
- DYN Medicinal Chemicals and Botanical Products
- Sector
- PLYM Real Estate
- DYN Health Care
- Exchange
- PLYM Nasdaq
- DYN Nasdaq
- Market Cap
- PLYM 794.4M
- DYN 848.8M
- IPO Year
- PLYM 2017
- DYN 2020
- Fundamental
- Price
- PLYM $15.57
- DYN $11.30
- Analyst Decision
- PLYM Buy
- DYN Strong Buy
- Analyst Count
- PLYM 9
- DYN 12
- Target Price
- PLYM $21.44
- DYN $47.73
- AVG Volume (30 Days)
- PLYM 392.8K
- DYN 2.7M
- Earning Date
- PLYM 05-01-2025
- DYN 05-08-2025
- Dividend Yield
- PLYM 6.14%
- DYN N/A
- EPS Growth
- PLYM 600.05
- DYN N/A
- EPS
- PLYM 3.05
- DYN N/A
- Revenue
- PLYM $180,505,000.00
- DYN N/A
- Revenue This Year
- PLYM $4.40
- DYN N/A
- Revenue Next Year
- PLYM $8.36
- DYN N/A
- P/E Ratio
- PLYM $5.13
- DYN N/A
- Revenue Growth
- PLYM N/A
- DYN N/A
- 52 Week Low
- PLYM $12.70
- DYN $6.36
- 52 Week High
- PLYM $24.71
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- PLYM 57.44
- DYN 55.04
- Support Level
- PLYM $15.05
- DYN $9.17
- Resistance Level
- PLYM $15.73
- DYN $12.47
- Average True Range (ATR)
- PLYM 0.41
- DYN 1.02
- MACD
- PLYM 0.19
- DYN 0.12
- Stochastic Oscillator
- PLYM 89.87
- DYN 73.65
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.